-
1.
公开(公告)号:US20240360228A1
公开(公告)日:2024-10-31
申请号:US18289993
申请日:2022-05-11
申请人: BIOLEGEND, INC.
发明人: JUAN MOYRON-QUIROZ , TAKATOKU OIDA
CPC分类号: C07K16/2866 , A61K49/0058 , G01N33/6863 , C07K2317/24 , C07K2317/76
摘要: Compositions and methods for making and using anti-CCR8 antibodies, antigen-binding fragments thereof, or agents, for example, monoclonal antibodies, CCR8-binding antibody fragments, and derivatives are described, as are kits, nucleic acids encoding such molecules, diagnostic reagents and kits that include anti-CCR8 antibodies, antigen-binding fragments thereof, or agents, and methods of making and using the same.
-
公开(公告)号:US20240145035A1
公开(公告)日:2024-05-02
申请号:US18497763
申请日:2023-10-30
申请人: BioLegend, Inc.
发明人: Santosh Putta , Nikil Wale , Wesley Jensen , Srikar Devakonda
摘要: A data structure relating to a sample of cells is described. The data structure includes first data elements each representing one of a number of first-degree nodes. Each of the first-degree nodes corresponds to a different one of a number of cellular constituents. Each first data element includes a quantitative indication of the portion of cells of the sample in which the constituent has positive expression. The data structure also includes second data elements each representing one of a number of greater-than-first-degree nodes, which each correspond to a different subset of the constituents of size two or more. Each second data element includes a quantitative indication of the portion of cells of the sample in which the subset of constituents all have positive expression. The contents of the data structure are usable to generate a visual co-expression graph characterizing the sample.
-
公开(公告)号:US20230160884A1
公开(公告)日:2023-05-25
申请号:US18099224
申请日:2023-01-19
申请人: BIOLEGEND, INC.
发明人: DHANESH GOHEL , HONG ZHANG , JOHN RANSOM
IPC分类号: G01N33/543 , G01N33/552
CPC分类号: G01N33/54326 , G01N33/552
摘要: Processes and compositions are described for preparing new, colloidally stable, coated nanomagnetic particles useful for both in-vitro and in-vivo biomedical applications, including cell targeting and capturing cells, microorganisms, and cellular organelles or entities such as exosomes. These nanomagnetic particles can also be used as imaging contrast agents due to their small size and high magnetic moment. The nanomagnetic particles include a series of sequentially added, stabilizing surface coatings rendered onto nano-sized magnetic crystal clusters (e.g., magnetite particles) to impart colloidal stability in complex biological samples with minimal leaching of the coating materials, high binding capacity, and low non-specific binding. Another benefit of this invention is the ability to utilize both external and internal magnetic field-generating separation devices to effect separation of the magnetic nanoparticles.
-
4.
公开(公告)号:US20240125806A1
公开(公告)日:2024-04-18
申请号:US18377228
申请日:2023-10-05
申请人: BIOLEGEND, INC. , TBJK GmbH
发明人: THOMAS BROCKER , JAN KRANICH , TILMAN KURZ , HONG ZHANG , HYUN PARK
IPC分类号: G01N33/92 , C07K14/485 , C12N9/52 , G01N33/569
CPC分类号: G01N33/92 , C07K14/485 , C12N9/52 , C12Y304/2207 , G01N33/56966 , C07K2319/60 , G01N2405/04
摘要: The present invention relates to a phosphatidylserine (PS) binding agents comprising one or more C-domains of a milk fat globule-EGF factor 8 (MFG-E8) protein, and methods of making and using the same.
-
公开(公告)号:US11584883B2
公开(公告)日:2023-02-21
申请号:US16702146
申请日:2019-12-03
申请人: BioLegend, Inc.
发明人: Xinshe Xu , Jing Wang , Matthew Yerou
摘要: The present disclosure provides fluorescent polyindenofluorene polymers or macromers with unique optical properties that are stable. The polymeric fluorophores are useful in various bioassays formats. The inventive polymers are useful in assays relying on fluorescence resonance energy transfer (FRET) mechanisms where two fluorophores are used.
-
公开(公告)号:US20220034906A1
公开(公告)日:2022-02-03
申请号:US17394238
申请日:2021-08-04
申请人: BIOLEGEND, INC.
IPC分类号: G01N33/68
摘要: The technology relates in part to methods for detecting the activity of Meteorin-β and modified versions thereof.
-
公开(公告)号:US20190119641A1
公开(公告)日:2019-04-25
申请号:US16096209
申请日:2017-04-30
申请人: BioLegend, Inc.
发明人: Dhanesh GOHEL , Hong ZHANG , John RAMSOM
摘要: Processes and compositions are provided for performing magnetibuoyant separations of different biomolecules (e.g., cells, organelles, etc.) in a biological sample, as well as compositions and kits for performing such methods. Compositions containing the separated biomolecules, and methods for using the same for in-vitro and in-vivo biomedical applications, are also provided. The magnetibuoyant methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.
-
公开(公告)号:US20230193246A1
公开(公告)日:2023-06-22
申请号:US17908821
申请日:2021-02-25
申请人: BIOLEGEND, Inc.
发明人: Andre Luiz Viera Zorzetto Fernandes , Craig Monell , Kristopher Nazor , David Soper , Carsten Wiethe , Xifeng Yang , Bertrand Yeung
IPC分类号: C12N15/10
CPC分类号: C12N15/1065
摘要: The disclosure relates in part to methods and compositions for detecting targets in a sample. Such methods and compositions can be useful for laboratory, research, and diagnostic purposes.
-
公开(公告)号:US11630104B2
公开(公告)日:2023-04-18
申请号:US16719337
申请日:2019-12-18
申请人: BIOLEGEND, INC.
发明人: Dhanesh Gohel , Hong Zhang , John Ransom
IPC分类号: G01N33/543 , G01N33/552
摘要: Processes and compositions are described for preparing new, colloidally stable, coated nanomagnetic particles useful for both in-vitro and in-vivo biomedical applications, including cell targeting and capturing cells, microorganisms, and cellular organelles or entities such as exosomes. These nanomagnetic particles can also be used as imaging contrast agents due to their small size and high magnetic moment. The nanomagnetic particles include a series of sequentially added, stabilizing surface coatings rendered onto nano-sized magnetic crystal clusters (e.g., magnetite particles) to impart colloidal stability in complex biological samples with minimal leaching of the coating materials, high binding capacity, and low non-specific binding. Another benefit of this invention is the ability to utilize both external and internal magnetic field-generating separation devices to effect separation of the magnetic nanoparticles.
-
公开(公告)号:US11608489B2
公开(公告)日:2023-03-21
申请号:US16096209
申请日:2017-04-30
申请人: BioLegend, Inc.
发明人: Dhanesh Gohel , Hong Zhang , John Ransom
IPC分类号: B01J20/06 , C12N5/0789 , G01N33/543 , C12N15/10 , G01N33/552 , B01J20/10 , B01J20/24 , B01J20/28 , C07K16/28 , C12N5/0783 , A61K35/28 , B01J20/32 , B03C1/015 , B03C1/28
摘要: The methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.
-
-
-
-
-
-
-
-
-